Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 410-415 , August 2010

Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer

Received 14 October 2009 ,Revised 16 December 2009 ,Accepted 26 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00002-2

doi: 10.1016/j.ctrv.2009.12.012

Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 410-415 , August 2010

Article Tools

* Image Usage & Resolution